Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Creatine market: $252 Mn against $11 Mn in 2023, about 23 times as large.
India grows faster: 9.3% a year, against 4.3%. The gap still grows from $241 Mn to $357 Mn by 2033.
Clinical research: 129 active trials in the US, 4 in India.
| Measure | ||
|---|---|---|
| Market size, 2023 | $252 Mn | $11 Mn |
| Market size, 2033 projected | $384 Mn | $27 Mn |
| Growth a year (CAGR) | 4.3% | 9.3% |
| Money added, 2023–2033 | $132 Mn | $16 Mn |
| Share of the world market | 42% | 1.8% |
| Size rank of 24 countries | #1 | #12 |
| Market per person, 2023 | $0.74 | $0.01 |
| Active clinical trials | 129 | 4 |
| Full report | US report | India report |
US India · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Creatine market: $252 Mn against $11 Mn in 2023, about 23 times as large.
India grows faster: 9.3% a year, against 4.3%. The gap still grows from $241 Mn to $357 Mn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.